Virus-Like Particle (VLP) Protein-isotype control

Catalog Number: UA060024 Brand: UA BIOSCIENCE

Price:

$158 USD

Size: 25μg 100μg 1mg

Quantity:

For shipping services or bulk orders, you may request a quotation.

Secure checkout with

View full details

Product Details

Product Specification

Species	HIV
Synonyms	VLP,Virus Like Particle,eVLP,VLPs
Concentration	0.27mg/ml by BCA
Expression System	HEK293
Molecular Weight	kDa&kDa
Conjugation	Unconjugated
Physical Appearance	Liquid
Storage Buffer	PBS, 5% trehalose, PH7.4
Stability & Storage	·6 months from date of receipt, -60 to -80 °C as supplied. ·about 3 days in 2 to 8 °C. ·Please avoid repeated freeze-thaw cycles.
Reference	Belghith AA, Cotter CA, Ignacio MA, Earl PL, Hills RA, Howarth MR, Yee DS, Brenchley JM, Moss B. Mpox multiprotein virus-like nanoparticle vaccine induces neutralizing and protective antibodies in mice and non-human primates. Nat Commun. 2025 May 21;16(1):4726.

Background

Virus-like particles (VLPs) are highly structured protein particles composed of single or multiple structural proteins of the virus. Its morphological structure is similar to that of natural virus particles, does not contain virus accounting, and has strong immunogenicity and biological activity. The empty shell structure of most VLP is icosahedral or helical structure, which is composed of several specific structural proteins. At present, it is widely used in vaccine production and antigen presentation.